We investigated the presence of antibodies against CD9, CD81 and CD82.
Few MS and AIDP patients had weakly reactive autoantibodies to CD9 or CD81.
None of NMO, AMAN and CIDP patients had antibodies to CD46, CD55 and CD59.
These proteins are unlikely targets for autoantibodies in demyelinating diseases.